The applicator will be phased out due to low demand, however bottles of Dovobet Gel will remain available.
LEO Pharma has announced plans to phase out its Dovobet Gel (calcipotriol/betamethasone dipropionate
gel) applicator from the beginning of summer 2019 in the UK, and autumn 2019 in Ireland, or earlier as and when existing stocks are depleted. This decision has been taken due to a lack of demand for the applicator. Please note that Dovobet Gel will remain available in bottles.
LEO apologises for any inconvenience caused by this product discontinuation, and recommends that anybody affected visits their healthcare professional to discuss their individual needs and preferences for the management of their psoriasis.
If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01844 347 333, or by email at email@example.com if you are in the UK.
If you are based in Ireland, you can reach LEO Pharma's Medical Information team either by phone on +353 1 490 89, or by email at firstname.lastname@example.org.
You can find more information about other currently unavailable treatments here